Team
Alexandra Pygall Head of life sciences and healthcare T: +44 20 7809 2137 M: +44 7881 314 566
View biography Email Alexandra Pygall | Vcard
Life Sciences and Healthcare
Straightforward, business-friendly advice from lawyers who understand the unique challenges and opportunities presented by the life sciences sector. We enjoy spending time getting to know our clients and working alongside them for the long term.
We work with a wide range of clients from the life sciences sector including:
- pharmaceutical companies
- biotechnology companies
- medical device and diagnostic companies
- manufacturers, distributors and logistics companies
- investors
- banks and financial institutions
Expertise
Insights
Celebrating women in life sciences and healthcare: insights and challenges from Hannah Kuchler
Law firm Stephenson Harwood LLP recently held an event for women in life sciences and healthcare, to celebrate International Women's Day and the achievements of women working in the sector. The evening included a fireside chat with the Emmy-nominated, Loeb-winning Hannah Kuchler, Global Pharmaceutical Editor for the Financial Times, and Alexandra Pygall, head of life sciences and healthcare at Stephenson Harwood.
Stephenson Harwood advises Dr. Falk on acquisition of Kynos Therapeutics
Stephenson Harwood LLP has advised Dr. Falk Pharma GmbH ('Dr. Falk'), a German multi-national pharmaceutical company, on its successful acquisition of Kynos Therapeutics Ltd ('Kynos'), a clinical stage biopharmaceutical company focusing on the development of novel treatments for patients suffering from acute and chronic inflammatory diseases.
Stephenson Harwood advises Hong Kong AI business on reverse merger and NASDAQ listing
Stephenson Harwood's Hong Kong corporate team has advised YOOV Group on its proposed reverse merger and listing on NASDAQ.
Stephenson Harwood advises on healthcare data acquisition
Stephenson Harwood LLP has acted for FPE Capital LLP on the acquisition by its portfolio company, Egress, of healthcare data migration specialist Stalis.
Stephenson Harwood advises Lansen Pharmaceutical on privatisation
Stephenson Harwood LLP acted as the Hong Kong legal adviser to Lansen Pharmaceutical Holdings Limited (Lansen Pharmaceutical) on its privatisation by Cathay International Pharma Manufacture And Distribution (China) Limited, involving a total consideration of approximately HK$240 million.